Frank Kensy, CEO & Co-Founder
Frank founded b.fab in 2018 and since then developed the company as managing director/CEO. He gained his entrepreneurial experience as founder and managing director of m2p-labs GmbH during 10 years growth of the company from a university spin-off to a worldwide leading supplier of microbioreactors and lab automation. m2p-labs was directly spun-off from his PhD thesis project with Prof. Jochen Büchs at RWTH Aachen. Before, he was group leader of the fermentation group at Rhein Biotech N.V. (today Dynavax) in Düsseldorf to develop bioprocesses for production of new recombinant enzymes and pharmaceutical proteins. Frank studied Biochemical Engineering at the University Essen, Madrid and at RWTH Aachen.
Armin Kubis, Head of Synthetic Biology
Armin joined the b.fab team in April 2021 as Head of Synthetic Biology. He is in charge of the molecular biology and metabolic engineering at b.fab. Armin holds a B.Sc. in Biochemistry from the University of Tübingen and a M.Sc. in Molecular Biosciences from the University of Heidelberg. For his PhD project he joined the lab of Arren Bar-Even, the inventor of the reductive glycine pathway and the Formate Bioeconomy, where he has gained fundamental experiences in metabolic engineering and strain construction.
Florent Collas, Head of Process Engineering
Florent joined b.fab in February 2021 as a Head of Process Engineering. He was previously involved in various white biotechnology projects aiming at producing bulk chemicals (isopropanol, butanol, isobutanol, isobutene…) from substrates of first, second (lignocellulosic biomass) and third (Syngas, CO2) generation. Within these projects, he gained experiences in bioprocess and metabolic engineering. Florent did his PhD between France (IFPEN in Rueil-Malmaison) and The Netherlands (Food and Biobased Research in Wageningen) and studied life sciences at the French “Grande École” AgroParisTech (former Institut National d’Agronomie Paris-Grignon).